

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.99410433 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.99410433 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21728228 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.06196531 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34152491 |
| 6 | positive regulation of defense response to virus by host (GO:0002230) | 4.26502821 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.25958981 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.24102945 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20877271 |
| 10 | adaptation of signaling pathway (GO:0023058) | 3.93232144 |
| 11 | negative regulation of phagocytosis (GO:0050765) | 3.87746860 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80539788 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.80002900 |
| 14 | viral transcription (GO:0019083) | 3.75047565 |
| 15 | mannose metabolic process (GO:0006013) | 3.65394227 |
| 16 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.64354640 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60793797 |
| 18 | translational termination (GO:0006415) | 3.57938915 |
| 19 | mannosylation (GO:0097502) | 3.54310722 |
| 20 | cornea development in camera-type eye (GO:0061303) | 3.50993591 |
| 21 | negative regulation of telomere maintenance (GO:0032205) | 3.50242143 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.42847171 |
| 23 | behavioral response to nicotine (GO:0035095) | 3.41616819 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.41543740 |
| 25 | leukocyte aggregation (GO:0070486) | 3.35243942 |
| 26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.34238530 |
| 27 | interferon-gamma production (GO:0032609) | 3.32923477 |
| 28 | cotranslational protein targeting to membrane (GO:0006613) | 3.24755564 |
| 29 | protein targeting to ER (GO:0045047) | 3.24242665 |
| 30 | positive regulation of protein kinase C signaling (GO:0090037) | 3.23690355 |
| 31 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22309562 |
| 32 | translational elongation (GO:0006414) | 3.19850775 |
| 33 | regulation of defense response to virus by host (GO:0050691) | 3.17200887 |
| 34 | actin nucleation (GO:0045010) | 3.16685532 |
| 35 | positive regulation of prostaglandin secretion (GO:0032308) | 3.14829113 |
| 36 | protein localization to endoplasmic reticulum (GO:0070972) | 3.11637578 |
| 37 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.07062091 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 3.06866702 |
| 39 | tolerance induction (GO:0002507) | 3.05872314 |
| 40 | T cell homeostasis (GO:0043029) | 3.02959024 |
| 41 | mast cell activation (GO:0045576) | 3.02859447 |
| 42 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.02365641 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.02077977 |
| 44 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.01932599 |
| 45 | regulation of chronic inflammatory response (GO:0002676) | 3.01745017 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.00378024 |
| 47 | regulation of protein heterodimerization activity (GO:0043497) | 2.98092156 |
| 48 | negative T cell selection (GO:0043383) | 2.96697327 |
| 49 | negative thymic T cell selection (GO:0045060) | 2.95655877 |
| 50 | response to pheromone (GO:0019236) | 2.94866543 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94494381 |
| 52 | metallo-sulfur cluster assembly (GO:0031163) | 2.93861692 |
| 53 | iron-sulfur cluster assembly (GO:0016226) | 2.93861692 |
| 54 | C-terminal protein lipidation (GO:0006501) | 2.92893810 |
| 55 | positive regulation of icosanoid secretion (GO:0032305) | 2.92241218 |
| 56 | positive thymic T cell selection (GO:0045059) | 2.91159214 |
| 57 | ribosomal small subunit biogenesis (GO:0042274) | 2.90798508 |
| 58 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.90003838 |
| 59 | GPI anchor metabolic process (GO:0006505) | 2.88591894 |
| 60 | positive regulation of fatty acid transport (GO:2000193) | 2.87775066 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 2.87620060 |
| 62 | viral life cycle (GO:0019058) | 2.86563831 |
| 63 | response to type I interferon (GO:0034340) | 2.85857868 |
| 64 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84139855 |
| 65 | kynurenine metabolic process (GO:0070189) | 2.83731599 |
| 66 | GPI anchor biosynthetic process (GO:0006506) | 2.83328217 |
| 67 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.83306791 |
| 68 | T cell migration (GO:0072678) | 2.83212882 |
| 69 | tRNA modification (GO:0006400) | 2.82030571 |
| 70 | cellular response to ATP (GO:0071318) | 2.81841262 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81011590 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 2.80613446 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 2.80613446 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.80613446 |
| 75 | type I interferon signaling pathway (GO:0060337) | 2.80277735 |
| 76 | cellular response to type I interferon (GO:0071357) | 2.80277735 |
| 77 | sulfate transmembrane transport (GO:1902358) | 2.79429327 |
| 78 | positive regulation of lamellipodium assembly (GO:0010592) | 2.78612191 |
| 79 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.78222313 |
| 80 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.78222313 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77724157 |
| 82 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.75323882 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74286027 |
| 84 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73249216 |
| 85 | response to interleukin-15 (GO:0070672) | 2.73166096 |
| 86 | piRNA metabolic process (GO:0034587) | 2.72921925 |
| 87 | cellular response to interferon-beta (GO:0035458) | 2.72580793 |
| 88 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71493435 |
| 89 | cellular protein complex disassembly (GO:0043624) | 2.70494480 |
| 90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70398761 |
| 91 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.69449032 |
| 92 | respiratory burst (GO:0045730) | 2.68973441 |
| 93 | opioid receptor signaling pathway (GO:0038003) | 2.68289526 |
| 94 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.67969423 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 2.66973484 |
| 96 | regulation of immunoglobulin secretion (GO:0051023) | 2.66751017 |
| 97 | definitive hemopoiesis (GO:0060216) | 2.66612216 |
| 98 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.65849944 |
| 99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65441664 |
| 100 | response to protozoan (GO:0001562) | 2.65193664 |
| 101 | angiogenesis involved in wound healing (GO:0060055) | 2.63946877 |
| 102 | ubiquinone biosynthetic process (GO:0006744) | 2.63603303 |
| 103 | protein K11-linked deubiquitination (GO:0035871) | 2.62767293 |
| 104 | necroptotic process (GO:0070266) | 2.62672021 |
| 105 | negative regulation of interleukin-1 production (GO:0032692) | 2.61697123 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.60260124 |
| 107 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.59834871 |
| 108 | regulation of response to interferon-gamma (GO:0060330) | 2.58974000 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.58607883 |
| 110 | B cell mediated immunity (GO:0019724) | 2.58133836 |
| 111 | translational initiation (GO:0006413) | 2.57712502 |
| 112 | DNA strand elongation (GO:0022616) | 2.57348841 |
| 113 | cellular biogenic amine catabolic process (GO:0042402) | 2.56944660 |
| 114 | amine catabolic process (GO:0009310) | 2.56944660 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55134599 |
| 116 | DNA deamination (GO:0045006) | 2.54922804 |
| 117 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.54446955 |
| 118 | thymic T cell selection (GO:0045061) | 2.54420500 |
| 119 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.54033589 |
| 120 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.53897923 |
| 121 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.53047985 |
| 122 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52670880 |
| 123 | lymphocyte homeostasis (GO:0002260) | 2.52182640 |
| 124 | mature B cell differentiation involved in immune response (GO:0002313) | 2.51729908 |
| 125 | base-excision repair, AP site formation (GO:0006285) | 2.51646901 |
| 126 | platelet dense granule organization (GO:0060155) | 2.50572461 |
| 127 | pentose-phosphate shunt (GO:0006098) | 2.50506431 |
| 128 | cellular response to zinc ion (GO:0071294) | 2.50072448 |
| 129 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.49358443 |
| 130 | positive regulation of histone deacetylation (GO:0031065) | 2.48576516 |
| 131 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47846253 |
| 132 | hepatocyte apoptotic process (GO:0097284) | 2.46206942 |
| 133 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.45674304 |
| 134 | defense response to protozoan (GO:0042832) | 2.44958487 |
| 135 | NAD biosynthetic process (GO:0009435) | 2.44439050 |
| 136 | DNA methylation involved in gamete generation (GO:0043046) | 2.43849688 |
| 137 | megakaryocyte development (GO:0035855) | 2.43496793 |
| 138 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41864260 |
| 139 | telomere maintenance via recombination (GO:0000722) | 2.41413869 |
| 140 | C-terminal protein amino acid modification (GO:0018410) | 2.41234469 |
| 141 | positive regulation of lamellipodium organization (GO:1902745) | 2.41219900 |
| 142 | regulation of cilium movement (GO:0003352) | 2.40967514 |
| 143 | auditory receptor cell stereocilium organization (GO:0060088) | 2.40937014 |
| 144 | maintenance of protein location in nucleus (GO:0051457) | 2.40812486 |
| 145 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.40572094 |
| 146 | L-fucose catabolic process (GO:0042355) | 2.40483356 |
| 147 | fucose catabolic process (GO:0019317) | 2.40483356 |
| 148 | L-fucose metabolic process (GO:0042354) | 2.40483356 |
| 149 | mature B cell differentiation (GO:0002335) | 2.40312114 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.40267422 |
| 151 | GDP-mannose metabolic process (GO:0019673) | 2.40132767 |
| 152 | positive regulation of macrophage differentiation (GO:0045651) | 2.39966872 |
| 153 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.39925721 |
| 154 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.39468659 |
| 155 | T-helper cell differentiation (GO:0042093) | 2.39468659 |
| 156 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39188475 |
| 157 | protein complex disassembly (GO:0043241) | 2.36861811 |
| 158 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.36680780 |
| 159 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.36275959 |
| 160 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.36223173 |
| 161 | positive regulation of interferon-alpha production (GO:0032727) | 2.34412926 |
| 162 | sulfate transport (GO:0008272) | 2.34344586 |
| 163 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.34170540 |
| 164 | cellular response to exogenous dsRNA (GO:0071360) | 2.33879442 |
| 165 | cytidine deamination (GO:0009972) | 2.33551138 |
| 166 | cytidine metabolic process (GO:0046087) | 2.33551138 |
| 167 | cytidine catabolic process (GO:0006216) | 2.33551138 |
| 168 | T cell apoptotic process (GO:0070231) | 2.33495866 |
| 169 | signal peptide processing (GO:0006465) | 2.32928187 |
| 170 | lymph node development (GO:0048535) | 2.32534725 |
| 171 | cell wall macromolecule metabolic process (GO:0044036) | 2.32262557 |
| 172 | purine-containing compound salvage (GO:0043101) | 2.31816548 |
| 173 | interferon-gamma secretion (GO:0072643) | 2.31072642 |
| 174 | glutathione biosynthetic process (GO:0006750) | 2.30821239 |
| 175 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.30759287 |
| 176 | negative regulation of cell killing (GO:0031342) | 2.30759287 |
| 177 | organic cation transport (GO:0015695) | 2.30289265 |
| 178 | regulation of regulatory T cell differentiation (GO:0045589) | 2.30257829 |
| 179 | valine metabolic process (GO:0006573) | 2.29827678 |
| 180 | response to interferon-beta (GO:0035456) | 2.29515078 |
| 181 | natural killer cell differentiation (GO:0001779) | 2.29398651 |
| 182 | leukocyte homeostasis (GO:0001776) | 2.29347751 |
| 183 | positive regulation of protein deacetylation (GO:0090312) | 2.28023103 |
| 184 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.27786410 |
| 185 | diterpenoid biosynthetic process (GO:0016102) | 2.27372530 |
| 186 | leukocyte cell-cell adhesion (GO:0007159) | 2.27168539 |
| 187 | myeloid dendritic cell activation (GO:0001773) | 2.26340843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68599852 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.62612299 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.98684912 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.84645367 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82560661 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.75699042 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.74194092 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64499072 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57213068 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52580222 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52289448 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.49714420 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45382039 |
| 14 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.42624800 |
| 15 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.40044482 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39484960 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38885018 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35980207 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29689382 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26874992 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.17267147 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11153029 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.09049178 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 2.08490156 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07606431 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06985803 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.02756424 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01801495 |
| 29 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01246550 |
| 30 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.01162757 |
| 31 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.99408579 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.96311855 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95839257 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.95224710 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91514721 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89131670 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87448746 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87369785 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86232002 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85559656 |
| 41 | ERA_21632823_ChIP-Seq_H3396_Human | 1.83536996 |
| 42 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79702863 |
| 43 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.79174520 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.77952247 |
| 45 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.77556072 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.75972311 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74812363 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.73147835 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71577617 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71405029 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71341357 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70072077 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68292815 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67999451 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.66958852 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66579327 |
| 57 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.65677341 |
| 58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65596634 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.64715500 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64205657 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61709419 |
| 62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60422180 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59828767 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56185560 |
| 65 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.55893749 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55277903 |
| 67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52564299 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52522200 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52498345 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52293274 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52182377 |
| 72 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50531726 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50113749 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49409565 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.47497806 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46407858 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45222861 |
| 78 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.44536262 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43659137 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42969166 |
| 81 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.42959134 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42495215 |
| 83 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.42010095 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41004428 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40723301 |
| 86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40612475 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39404517 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38658369 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38113391 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 1.35580377 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35370273 |
| 92 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34994131 |
| 93 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34555736 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.32950197 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32248841 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.32007563 |
| 97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.31608187 |
| 98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28973775 |
| 99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.28644267 |
| 100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27533867 |
| 101 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26879040 |
| 102 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26436405 |
| 103 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.25937856 |
| 104 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24407541 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24084241 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24081879 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.24028498 |
| 108 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23363796 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.23337323 |
| 110 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23161775 |
| 111 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20474402 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20159893 |
| 113 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.20148354 |
| 114 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.19652716 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18280022 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17802320 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17754570 |
| 118 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17187261 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16573126 |
| 120 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.16387475 |
| 121 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15676969 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15457174 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15158678 |
| 124 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14690902 |
| 125 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14198003 |
| 126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13579588 |
| 127 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.13377592 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12876392 |
| 129 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12653342 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12427567 |
| 131 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12063455 |
| 132 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.10947103 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10391676 |
| 134 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10303133 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10194187 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08578887 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08465031 |
| 138 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.08005642 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07666270 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07523585 |
| 141 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07350157 |
| 142 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06948000 |
| 143 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05882866 |
| 144 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05878414 |
| 145 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05384056 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05361820 |
| 147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04546264 |
| 148 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03938597 |
| 149 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02665174 |
| 150 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02526356 |
| 151 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02472835 |
| 152 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01981046 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01488474 |
| 154 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01144533 |
| 155 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99467267 |
| 156 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99152559 |
| 157 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.98944712 |
| 158 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98463111 |
| 159 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97607673 |
| 160 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96819405 |
| 161 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96731000 |
| 162 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96638271 |
| 163 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94897592 |
| 164 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.93387773 |
| 165 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93237758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.31269768 |
| 2 | MP0000685_abnormal_immune_system | 2.92876784 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.85123296 |
| 4 | MP0003436_decreased_susceptibility_to | 2.72958682 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.63297815 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.63199222 |
| 7 | MP0001800_abnormal_humoral_immune | 2.60811878 |
| 8 | MP0005671_abnormal_response_to | 2.58689934 |
| 9 | MP0009785_altered_susceptibility_to | 2.58502275 |
| 10 | MP0005387_immune_system_phenotype | 2.51709219 |
| 11 | MP0001790_abnormal_immune_system | 2.51709219 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.41674207 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.40117558 |
| 14 | MP0005025_abnormal_response_to | 2.37723040 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.34677633 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.33883197 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.31717053 |
| 18 | MP0002723_abnormal_immune_serum | 2.31530511 |
| 19 | MP0001819_abnormal_immune_cell | 2.28875356 |
| 20 | MP0002398_abnormal_bone_marrow | 2.25120688 |
| 21 | MP0003011_delayed_dark_adaptation | 2.21503911 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.16826187 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.15708232 |
| 24 | MP0002419_abnormal_innate_immunity | 2.13145253 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.06939913 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.06742290 |
| 27 | MP0003724_increased_susceptibility_to | 2.00954703 |
| 28 | MP0000716_abnormal_immune_system | 2.00839395 |
| 29 | MP0002405_respiratory_system_inflammati | 1.97586125 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.96511672 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.94729828 |
| 32 | MP0002722_abnormal_immune_system | 1.94218350 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.88894980 |
| 34 | MP0002006_tumorigenesis | 1.84207619 |
| 35 | MP0000490_abnormal_crypts_of | 1.80953313 |
| 36 | MP0002429_abnormal_blood_cell | 1.78970491 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.78224677 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.78224677 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.75966475 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.74718669 |
| 41 | MP0001873_stomach_inflammation | 1.72790547 |
| 42 | MP0009840_abnormal_foam_cell | 1.72764705 |
| 43 | MP0003303_peritoneal_inflammation | 1.70857323 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.70009402 |
| 45 | MP0001853_heart_inflammation | 1.66329700 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.66269202 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.65272771 |
| 48 | MP0004043_abnormal_pH_regulation | 1.64522313 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.63427641 |
| 50 | MP0004947_skin_inflammation | 1.63384091 |
| 51 | MP0008872_abnormal_physiological_respon | 1.63033696 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.60679113 |
| 53 | MP0003866_abnormal_defecation | 1.58759562 |
| 54 | MP0004133_heterotaxia | 1.56875954 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.50999327 |
| 56 | MP0003787_abnormal_imprinting | 1.49490782 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.45414387 |
| 58 | MP0000858_altered_metastatic_potential | 1.44960128 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.43174064 |
| 60 | MP0006082_CNS_inflammation | 1.40548629 |
| 61 | MP0008469_abnormal_protein_level | 1.39929310 |
| 62 | MP0003646_muscle_fatigue | 1.38984972 |
| 63 | MP0006054_spinal_hemorrhage | 1.37674577 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 1.37340001 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.36006987 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.35880687 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.35520006 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.35256821 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.35075683 |
| 70 | MP0002933_joint_inflammation | 1.34523284 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.33749076 |
| 72 | MP0001764_abnormal_homeostasis | 1.33037104 |
| 73 | MP0005360_urolithiasis | 1.32846523 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.31455591 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.29193201 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.28336720 |
| 77 | MP0002102_abnormal_ear_morphology | 1.24550931 |
| 78 | MP0002254_reproductive_system_inflammat | 1.24117976 |
| 79 | MP0001663_abnormal_digestive_system | 1.23212896 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.22834106 |
| 81 | MP0004381_abnormal_hair_follicle | 1.21816394 |
| 82 | MP0003077_abnormal_cell_cycle | 1.20049059 |
| 83 | MP0005023_abnormal_wound_healing | 1.19954778 |
| 84 | MP0000538_abnormal_urinary_bladder | 1.15756153 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.09992558 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.08461206 |
| 87 | MP0002132_abnormal_respiratory_system | 1.07379111 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 1.07368512 |
| 89 | MP0004510_myositis | 1.06124844 |
| 90 | MP0000372_irregular_coat_pigmentation | 1.05670497 |
| 91 | MP0003283_abnormal_digestive_organ | 1.03767489 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 1.03686595 |
| 93 | MP0001765_abnormal_ion_homeostasis | 1.03590135 |
| 94 | MP0000609_abnormal_liver_physiology | 1.01613788 |
| 95 | MP0002735_abnormal_chemical_nociception | 1.00494912 |
| 96 | MP0000343_altered_response_to | 1.00462546 |
| 97 | MP0003195_calcinosis | 1.00296163 |
| 98 | MP0010094_abnormal_chromosome_stability | 0.99946212 |
| 99 | MP0001944_abnormal_pancreas_morphology | 0.99880214 |
| 100 | MP0009764_decreased_sensitivity_to | 0.99810148 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.99678916 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.99548877 |
| 103 | MP0003448_altered_tumor_morphology | 0.99318926 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.99211306 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.99127692 |
| 106 | MP0002653_abnormal_ependyma_morphology | 0.98874014 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.97273047 |
| 108 | MP0002736_abnormal_nociception_after | 0.95278096 |
| 109 | MP0004957_abnormal_blastocyst_morpholog | 0.94778001 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.92349994 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.92173626 |
| 112 | MP0009763_increased_sensitivity_to | 0.91560316 |
| 113 | MP0003045_fibrosis | 0.90884423 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.90296423 |
| 115 | MP0000598_abnormal_liver_morphology | 0.90157308 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.89325583 |
| 117 | MP0010307_abnormal_tumor_latency | 0.89072716 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.87987530 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.87237349 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.86729872 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.86115013 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.84940110 |
| 123 | MP0009278_abnormal_bone_marrow | 0.84730336 |
| 124 | MP0005410_abnormal_fertilization | 0.84413069 |
| 125 | MP0005535_abnormal_body_temperature | 0.83497721 |
| 126 | MP0003186_abnormal_redox_activity | 0.83077237 |
| 127 | MP0005310_abnormal_salivary_gland | 0.82978436 |
| 128 | MP0008789_abnormal_olfactory_epithelium | 0.82339376 |
| 129 | MP0000371_diluted_coat_color | 0.82197777 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.80897902 |
| 131 | MP0001919_abnormal_reproductive_system | 0.80326478 |
| 132 | MP0005174_abnormal_tail_pigmentation | 0.80171783 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.79689424 |
| 134 | MP0003279_aneurysm | 0.78741963 |
| 135 | MP0008873_increased_physiological_sensi | 0.78332680 |
| 136 | MP0008995_early_reproductive_senescence | 0.75654171 |
| 137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75243632 |
| 138 | MP0002139_abnormal_hepatobiliary_system | 0.75241050 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.74495494 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.74433386 |
| 141 | MP0002138_abnormal_hepatobiliary_system | 0.74410029 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.73942523 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.71802169 |
| 144 | MP0000249_abnormal_blood_vessel | 0.71725852 |
| 145 | MP0005365_abnormal_bile_salt | 0.69701050 |
| 146 | MP0000313_abnormal_cell_death | 0.68179944 |
| 147 | MP0005166_decreased_susceptibility_to | 0.67689552 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.65178865 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.64840271 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64547772 |
| 151 | MP0001243_abnormal_dermal_layer | 0.64545424 |
| 152 | MP0003091_abnormal_cell_migration | 0.62938051 |
| 153 | MP0003795_abnormal_bone_structure | 0.62228328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 4.64760801 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.48706957 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.21533360 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.17645947 |
| 5 | IgM deficiency (HP:0002850) | 4.17061794 |
| 6 | Myositis (HP:0100614) | 4.16840939 |
| 7 | Chronic otitis media (HP:0000389) | 4.06229131 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.80902777 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.57102826 |
| 10 | J-shaped sella turcica (HP:0002680) | 3.47563324 |
| 11 | Recurrent viral infections (HP:0004429) | 3.46253803 |
| 12 | Type II lissencephaly (HP:0007260) | 3.42559612 |
| 13 | Molar tooth sign on MRI (HP:0002419) | 3.35568286 |
| 14 | Abnormality of midbrain morphology (HP:0002418) | 3.35568286 |
| 15 | Cellulitis (HP:0100658) | 3.32258888 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.30963174 |
| 17 | Pancreatic cysts (HP:0001737) | 3.28376362 |
| 18 | Petechiae (HP:0000967) | 3.20377661 |
| 19 | Nephronophthisis (HP:0000090) | 3.17999496 |
| 20 | Abnormality of T cells (HP:0002843) | 3.15893252 |
| 21 | True hermaphroditism (HP:0010459) | 3.10080781 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.09271924 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.07640836 |
| 24 | T lymphocytopenia (HP:0005403) | 3.05523052 |
| 25 | Congenital stationary night blindness (HP:0007642) | 3.05397054 |
| 26 | Nasal polyposis (HP:0100582) | 3.04964275 |
| 27 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.02679244 |
| 28 | Pancreatic fibrosis (HP:0100732) | 3.00953765 |
| 29 | Meningitis (HP:0001287) | 3.00013677 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.98598122 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.98049358 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.90338031 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90315969 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.85035937 |
| 35 | Epistaxis (HP:0000421) | 2.80767885 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.79679228 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.78251718 |
| 38 | Pendular nystagmus (HP:0012043) | 2.78024141 |
| 39 | Aplastic anemia (HP:0001915) | 2.77856941 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.77185510 |
| 41 | Cystic liver disease (HP:0006706) | 2.76936977 |
| 42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.76664114 |
| 43 | Pustule (HP:0200039) | 2.72456675 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.72131827 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.71457857 |
| 46 | Abnormal number of erythroid precursors (HP:0012131) | 2.69224108 |
| 47 | Attenuation of retinal blood vessels (HP:0007843) | 2.68524499 |
| 48 | Recurrent skin infections (HP:0001581) | 2.66923673 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64786442 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.63339956 |
| 51 | B lymphocytopenia (HP:0010976) | 2.63339956 |
| 52 | Lymphopenia (HP:0001888) | 2.63159827 |
| 53 | Mesangial abnormality (HP:0001966) | 2.61647121 |
| 54 | Gingival bleeding (HP:0000225) | 2.61411407 |
| 55 | Abnormal platelet function (HP:0011869) | 2.60571697 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.60571697 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.59582185 |
| 58 | Cerebellar dysplasia (HP:0007033) | 2.57629659 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57291796 |
| 60 | Abnormality of the renal medulla (HP:0100957) | 2.54651266 |
| 61 | Reticulocytopenia (HP:0001896) | 2.54438511 |
| 62 | Vasculitis (HP:0002633) | 2.52770058 |
| 63 | Optic nerve coloboma (HP:0000588) | 2.51408276 |
| 64 | Abnormal drinking behavior (HP:0030082) | 2.50063918 |
| 65 | Polydipsia (HP:0001959) | 2.50063918 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.49786267 |
| 67 | Abnormal platelet volume (HP:0011876) | 2.47771321 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.46345335 |
| 69 | IgG deficiency (HP:0004315) | 2.45915253 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43904145 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43904145 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43904145 |
| 73 | Orchitis (HP:0100796) | 2.41725257 |
| 74 | Tubular atrophy (HP:0000092) | 2.41192668 |
| 75 | Ketosis (HP:0001946) | 2.40804887 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.39210942 |
| 77 | Mitochondrial inheritance (HP:0001427) | 2.38987845 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.38418276 |
| 79 | Combined immunodeficiency (HP:0005387) | 2.37432491 |
| 80 | Keratitis (HP:0000491) | 2.36586761 |
| 81 | Hepatic necrosis (HP:0002605) | 2.36454048 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35824153 |
| 83 | Obstructive lung disease (HP:0006536) | 2.35824153 |
| 84 | Increased IgE level (HP:0003212) | 2.35542995 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.34403953 |
| 86 | Purpura (HP:0000979) | 2.34259553 |
| 87 | Stomach cancer (HP:0012126) | 2.32350521 |
| 88 | Severe muscular hypotonia (HP:0006829) | 2.32166696 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 2.30819751 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.30782501 |
| 91 | Occipital encephalocele (HP:0002085) | 2.30451633 |
| 92 | Large for gestational age (HP:0001520) | 2.30287733 |
| 93 | Arterial thrombosis (HP:0004420) | 2.29118602 |
| 94 | Increased IgM level (HP:0003496) | 2.28833179 |
| 95 | Progressive microcephaly (HP:0000253) | 2.28058122 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.28037146 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28037146 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.27704512 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27704512 |
| 100 | Abnormality of lateral ventricle (HP:0030047) | 2.25773688 |
| 101 | Encephalitis (HP:0002383) | 2.24595347 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 2.22837813 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 2.22168785 |
| 104 | Stomatitis (HP:0010280) | 2.20651009 |
| 105 | Conical tooth (HP:0000698) | 2.18048379 |
| 106 | Decreased circulating renin level (HP:0003351) | 2.17316136 |
| 107 | Verrucae (HP:0200043) | 2.15821140 |
| 108 | Papilloma (HP:0012740) | 2.15821140 |
| 109 | Severe combined immunodeficiency (HP:0004430) | 2.15507079 |
| 110 | Nonimmune hydrops fetalis (HP:0001790) | 2.15197358 |
| 111 | Osteomyelitis (HP:0002754) | 2.14681184 |
| 112 | Increased serum ferritin (HP:0003281) | 2.13869495 |
| 113 | Chest pain (HP:0100749) | 2.13084656 |
| 114 | Severe visual impairment (HP:0001141) | 2.12998873 |
| 115 | Congenital hepatic fibrosis (HP:0002612) | 2.12044237 |
| 116 | Abnormality of the prostate (HP:0008775) | 2.09611518 |
| 117 | Leukocytosis (HP:0001974) | 2.09463848 |
| 118 | Microcytic anemia (HP:0001935) | 2.09238079 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 2.08534660 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07277729 |
| 121 | IgA deficiency (HP:0002720) | 2.07209431 |
| 122 | Lymphoma (HP:0002665) | 2.05420132 |
| 123 | Tented upper lip vermilion (HP:0010804) | 2.05163714 |
| 124 | Concave nail (HP:0001598) | 2.03841270 |
| 125 | Increased CSF lactate (HP:0002490) | 2.03806341 |
| 126 | Thoracic kyphosis (HP:0002942) | 2.02469437 |
| 127 | Cerebral palsy (HP:0100021) | 2.01763039 |
| 128 | Entropion (HP:0000621) | 2.00024719 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 1.99988508 |
| 130 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99519221 |
| 131 | Eosinophilia (HP:0001880) | 1.99306716 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 1.99296834 |
| 133 | Bile duct proliferation (HP:0001408) | 1.99296834 |
| 134 | Joint stiffness (HP:0001387) | 1.99283449 |
| 135 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.98667984 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.97968031 |
| 137 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.97219735 |
| 138 | Recurrent cutaneous fungal infections (HP:0011370) | 1.97219735 |
| 139 | Autoimmune hemolytic anemia (HP:0001890) | 1.96831028 |
| 140 | Abnormality of the fingertips (HP:0001211) | 1.96493326 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95524113 |
| 142 | Pallor (HP:0000980) | 1.95311189 |
| 143 | Large eyes (HP:0001090) | 1.94910100 |
| 144 | Ketoacidosis (HP:0001993) | 1.94422868 |
| 145 | Emphysema (HP:0002097) | 1.93529692 |
| 146 | Skin rash (HP:0000988) | 1.93302479 |
| 147 | Colitis (HP:0002583) | 1.92835974 |
| 148 | Acute necrotizing encephalopathy (HP:0006965) | 1.92830228 |
| 149 | Joint swelling (HP:0001386) | 1.92822581 |
| 150 | Granulocytopenia (HP:0001913) | 1.92603180 |
| 151 | Skin ulcer (HP:0200042) | 1.91642915 |
| 152 | Poikiloderma (HP:0001029) | 1.91338592 |
| 153 | Abnormality of iron homeostasis (HP:0011031) | 1.91126197 |
| 154 | Multiple enchondromatosis (HP:0005701) | 1.90828103 |
| 155 | Hypoplasia of the pons (HP:0012110) | 1.89689014 |
| 156 | Broad face (HP:0000283) | 1.89559220 |
| 157 | Recurrent sinusitis (HP:0011108) | 1.89123505 |
| 158 | Bronchitis (HP:0012387) | 1.88865311 |
| 159 | Optic neuritis (HP:0100653) | 1.87809329 |
| 160 | Retrobulbar optic neuritis (HP:0100654) | 1.87809329 |
| 161 | Microretrognathia (HP:0000308) | 1.86123895 |
| 162 | Abnormality of the pons (HP:0007361) | 1.85874411 |
| 163 | Polyuria (HP:0000103) | 1.85790609 |
| 164 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84873372 |
| 165 | Hypoplasia of the thymus (HP:0000778) | 1.82675887 |
| 166 | Neurodegeneration (HP:0002180) | 1.82549802 |
| 167 | Medial flaring of the eyebrow (HP:0010747) | 1.82339339 |
| 168 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81985195 |
| 169 | Male pseudohermaphroditism (HP:0000037) | 1.81562117 |
| 170 | Urticaria (HP:0001025) | 1.81453541 |
| 171 | Chronic sinusitis (HP:0011109) | 1.80006833 |
| 172 | Testicular atrophy (HP:0000029) | 1.79503721 |
| 173 | Tachypnea (HP:0002789) | 1.76787036 |
| 174 | Furrowed tongue (HP:0000221) | 1.75724423 |
| 175 | Methylmalonic aciduria (HP:0012120) | 1.74835322 |
| 176 | Optic disc pallor (HP:0000543) | 1.74743530 |
| 177 | Hypoplasia of the fovea (HP:0007750) | 1.74723968 |
| 178 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.74723968 |
| 179 | Clumsiness (HP:0002312) | 1.74155116 |
| 180 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.74034660 |
| 181 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.74034660 |
| 182 | Acute encephalopathy (HP:0006846) | 1.73290899 |
| 183 | Increased corneal curvature (HP:0100692) | 1.72546438 |
| 184 | Keratoconus (HP:0000563) | 1.72546438 |
| 185 | Increased serum lactate (HP:0002151) | 1.71830123 |
| 186 | Abolished electroretinogram (ERG) (HP:0000550) | 1.71500458 |
| 187 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.71077716 |
| 188 | Abnormal albumin level (HP:0012116) | 1.70921361 |
| 189 | Hypoalbuminemia (HP:0003073) | 1.70921361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.38015508 |
| 2 | MAP4K2 | 2.73053552 |
| 3 | NME2 | 2.53955183 |
| 4 | PKN2 | 2.53001422 |
| 5 | ADRBK2 | 2.51758773 |
| 6 | SIK2 | 2.50355156 |
| 7 | ERN1 | 2.49357821 |
| 8 | EEF2K | 2.33044524 |
| 9 | TLK1 | 2.21064920 |
| 10 | FRK | 2.20118137 |
| 11 | ZAP70 | 2.17979673 |
| 12 | JAK3 | 2.13723784 |
| 13 | TXK | 2.13373489 |
| 14 | VRK2 | 2.12621297 |
| 15 | PIM2 | 2.11312790 |
| 16 | KIT | 2.07281256 |
| 17 | TBK1 | 2.06396860 |
| 18 | TRIB3 | 2.04730651 |
| 19 | ZAK | 2.04674519 |
| 20 | TYK2 | 2.04143685 |
| 21 | MUSK | 2.01011978 |
| 22 | FLT3 | 1.97610337 |
| 23 | MAP3K10 | 1.96758724 |
| 24 | KDR | 1.95090596 |
| 25 | TEC | 1.94191206 |
| 26 | GRK6 | 1.91753677 |
| 27 | MAPK15 | 1.91685651 |
| 28 | BTK | 1.90235812 |
| 29 | STK10 | 1.86730405 |
| 30 | LRRK2 | 1.82327649 |
| 31 | MAP2K3 | 1.78458318 |
| 32 | SCYL2 | 1.68990751 |
| 33 | MAPK13 | 1.66647418 |
| 34 | PRKD2 | 1.66059957 |
| 35 | GRK1 | 1.59149724 |
| 36 | WNK4 | 1.57488207 |
| 37 | TESK2 | 1.57018439 |
| 38 | TAOK2 | 1.55204370 |
| 39 | CSF1R | 1.54290674 |
| 40 | PTK2B | 1.53319740 |
| 41 | ITK | 1.51209741 |
| 42 | BLK | 1.50493635 |
| 43 | MAP3K14 | 1.50311004 |
| 44 | INSRR | 1.48260540 |
| 45 | RPS6KA4 | 1.46769301 |
| 46 | IKBKE | 1.46227433 |
| 47 | SIK3 | 1.44045439 |
| 48 | IRAK1 | 1.37499773 |
| 49 | PIM1 | 1.34946634 |
| 50 | NUAK1 | 1.34020794 |
| 51 | FGFR4 | 1.26987135 |
| 52 | MAP3K11 | 1.26170242 |
| 53 | TGFBR1 | 1.25842238 |
| 54 | ACVR1B | 1.25234155 |
| 55 | SYK | 1.25146545 |
| 56 | NEK2 | 1.21586365 |
| 57 | CLK1 | 1.18665203 |
| 58 | WNK3 | 1.15655582 |
| 59 | TIE1 | 1.15189965 |
| 60 | IKBKB | 1.14616513 |
| 61 | MAP3K12 | 1.14303702 |
| 62 | JAK1 | 1.12552936 |
| 63 | LCK | 1.11870088 |
| 64 | RPS6KA2 | 1.10488395 |
| 65 | NME1 | 1.06855149 |
| 66 | NLK | 1.04292214 |
| 67 | BUB1 | 1.02798115 |
| 68 | BRSK2 | 0.99259515 |
| 69 | TGFBR2 | 0.98124266 |
| 70 | MARK3 | 0.96391520 |
| 71 | PINK1 | 0.91623449 |
| 72 | WEE1 | 0.89582001 |
| 73 | TRPM7 | 0.88646517 |
| 74 | TAOK1 | 0.88509786 |
| 75 | MAP3K3 | 0.87304055 |
| 76 | STK4 | 0.87266747 |
| 77 | LYN | 0.87082726 |
| 78 | ILK | 0.86463478 |
| 79 | HCK | 0.85979424 |
| 80 | IRAK4 | 0.85483624 |
| 81 | NEK9 | 0.84574671 |
| 82 | RPS6KB2 | 0.84007222 |
| 83 | CDK8 | 0.83898904 |
| 84 | TAOK3 | 0.82695055 |
| 85 | PRKCI | 0.81597873 |
| 86 | IRAK2 | 0.81095103 |
| 87 | MAP3K8 | 0.79330936 |
| 88 | BCKDK | 0.75741596 |
| 89 | MAP2K2 | 0.75415528 |
| 90 | DAPK2 | 0.75395401 |
| 91 | JAK2 | 0.72547839 |
| 92 | CDK4 | 0.70721991 |
| 93 | PAK4 | 0.69478590 |
| 94 | RPS6KA5 | 0.69367759 |
| 95 | TESK1 | 0.68131937 |
| 96 | EPHA2 | 0.67913325 |
| 97 | MAPK11 | 0.67611782 |
| 98 | VRK1 | 0.67282315 |
| 99 | TTN | 0.66605514 |
| 100 | EPHA3 | 0.65432066 |
| 101 | CSK | 0.64743050 |
| 102 | RIPK4 | 0.63697961 |
| 103 | CAMKK1 | 0.62603806 |
| 104 | SIK1 | 0.61357835 |
| 105 | CHUK | 0.59933802 |
| 106 | MAP3K13 | 0.58946970 |
| 107 | PTK6 | 0.58669045 |
| 108 | ADRBK1 | 0.58462628 |
| 109 | MATK | 0.57715166 |
| 110 | RPS6KA6 | 0.56807067 |
| 111 | TNK2 | 0.55603665 |
| 112 | MAP3K7 | 0.55117129 |
| 113 | MAPKAPK3 | 0.54236409 |
| 114 | MAPK12 | 0.53463877 |
| 115 | MAP3K6 | 0.53124745 |
| 116 | FGFR3 | 0.52096500 |
| 117 | CDK6 | 0.51985873 |
| 118 | MAP3K5 | 0.51622888 |
| 119 | EPHB1 | 0.50511792 |
| 120 | AURKB | 0.49880323 |
| 121 | BRSK1 | 0.49855839 |
| 122 | MAP2K6 | 0.49080079 |
| 123 | FES | 0.49070492 |
| 124 | MAPK4 | 0.48589435 |
| 125 | HIPK2 | 0.47415652 |
| 126 | PRKG2 | 0.47091559 |
| 127 | MARK2 | 0.46968520 |
| 128 | PRKCQ | 0.45360066 |
| 129 | MYLK | 0.43997701 |
| 130 | CDK7 | 0.43495573 |
| 131 | RAF1 | 0.43035279 |
| 132 | RPS6KL1 | 0.42819229 |
| 133 | RPS6KC1 | 0.42819229 |
| 134 | GRK7 | 0.41018768 |
| 135 | PRKCH | 0.40226101 |
| 136 | PASK | 0.39357255 |
| 137 | CAMKK2 | 0.38438972 |
| 138 | IRAK3 | 0.37775704 |
| 139 | MAPKAPK5 | 0.37670861 |
| 140 | BMPR1B | 0.37483074 |
| 141 | MAPK7 | 0.35589177 |
| 142 | PRKAA2 | 0.34118086 |
| 143 | STK16 | 0.33616372 |
| 144 | RPS6KA1 | 0.32405134 |
| 145 | MAPK3 | 0.32392065 |
| 146 | PRKAA1 | 0.32218394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25794047 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.20013485 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.09945003 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.80796480 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.43948282 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.40364635 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.38213443 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.27847585 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.22306804 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.17126514 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11962642 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06368976 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04707412 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.00469508 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.96747292 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94151339 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88284906 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87843915 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79347181 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79104511 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76665572 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75163694 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75022777 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72183975 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.69784735 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66168002 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.64341503 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.61392961 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61019612 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56949340 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.53376321 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.52186177 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51333892 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49551907 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43451834 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.41742110 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41126848 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40263443 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37720654 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31396833 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31226115 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28639473 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.28588888 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26444329 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.24282597 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23728844 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.23007404 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21414732 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.20428536 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20398275 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20091758 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17306172 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16998927 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15844633 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14812185 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.14651514 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.14142574 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12227911 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12142883 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11596977 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10808316 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09642043 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 1.09123016 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07833827 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06096154 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 1.03084339 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.02352275 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01998595 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01661992 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01076438 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.98792157 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98774639 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98698866 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97803154 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97784761 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97509856 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97217336 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.94841770 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.94748093 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93933809 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93624872 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.91683909 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89852166 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89496598 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.86434741 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84756481 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.84320044 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.84131152 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83574785 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80858320 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80699204 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.80087110 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79880963 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78875341 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78510404 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77985269 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77704367 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77564054 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76225729 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76206173 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.75368006 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75260689 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74558793 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.72128852 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71215341 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69487773 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68988575 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65662524 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.64797648 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64710063 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63861029 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61607373 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60838070 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60692705 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59877436 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59588956 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59443236 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58330438 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58028351 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57247843 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56232073 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55742151 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54652999 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54497717 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.53811971 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53759140 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.52908098 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52769077 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52270879 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51971190 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50919266 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49246095 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48693698 |
| 134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47349244 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.45204137 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44733342 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43168763 |
| 138 | RNA degradation_Homo sapiens_hsa03018 | 0.42570597 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40951247 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40316706 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38791593 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38005262 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37907387 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37709803 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37392329 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37271137 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37096635 |
| 148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35856176 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35501653 |
| 150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32948262 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29436064 |
| 152 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29140899 |

